Tech Company Financing Transactions
GT Metabolic Solutions Funding Round
GT Metabolic Solutions, based in St Michael, secured investment capital from J.P. Morgan.
Transaction Overview
Company Name
Announced On
10/28/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to support its ongoing global commercial launch and fund expansion into new surgical and therapeutic settings, including endoscopic and colorectal surgery.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5450 Quam Ave NE
St Michael, MN 55376
USA
St Michael, MN 55376
USA
Phone
Website
Email Address
Overview
The vision of GT Metabolic� is to complement and expand the MBS market. We offer a portfolio of MIS products and techniques that benefit both patients and surgeons. Our solutions are incisionless, inexpensive, leave no foreign bodies, are reversible, and facilitate staging of procedures in the outpatient setting. Focused for launch in the metabolic/bariatric surgery space, the technology has the potential to disrupt other fields, including gastrointestinal, thoracic, biliary, colorectal, urological, and vascular surgery in the near future.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thierry Thaure
Chief Marketing Officer
Michel Gagner
VP - Finance
Kate Taylor
VP - Operations
Mike Reiland
VP - R & D
Todd Krinke
VP - Regulatory Affairs
Lisa Vincent
VP - Sales
Marcus Voss
Browse more venture capital transactions:
Prev: 10/28/2026: Plato Technologies venture capital transaction
Next: 10/28/2026: ClarityCare venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs